DNA Replication Timing Is Maintained Genome-Wide in Primary Human Myoblasts Independent of D4Z4 Contraction in FSH Muscular Dystrophy

Facioscapulohumeral muscular dystrophy (FSHD) is linked to contraction of an array of tandem 3.3-kb repeats (D4Z4) at 4q35.2 from 11-100 copies to 1-10 copies. The extent to which D4Z4 contraction at 4q35.2 affects overall 4q35.2 chromatin organization remains unclear. Because DNA replication timing is highly predictive of long-range chromatin interactions, we generated genome-wide replication-timing profiles for FSHD and control myogenic precursor cells. We compared non-immortalized myoblasts from four FSHD patients and three control individuals to each other and to a variety of other human cell types. This study also represents the first genome-wide comparison of replication timing profiles in non-immortalized human cell cultures. Myoblasts from both control and FSHD individuals all shared a myoblast-specific replication profile. In contrast, male and female individuals were readily distinguished by monoallelic differences in replication timing at DXZ4 and other regions across the X chromosome affected by X inactivation. We conclude that replication timing is a robust cell-type specific feature that is unaffected by FSHD-related D4Z4 contraction.

[1]  U. Francke,et al.  A novel GC–rich human macrosatellite VNTR in Xq24 is differentially methylated on active and inactive X chromosomes , 1992, Nature Genetics.

[2]  T. Canfield,et al.  Role of late replication timing in the silencing of X-linked genes. , 1996, Human molecular genetics.

[3]  H. Ding,et al.  Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. , 1999, Gene.

[4]  Michael R. Green,et al.  Inappropriate Gene Activation in FSHD A Repressor Complex Binds a Chromosomal Repeat Deleted in Dystrophic Muscle , 2002, Cell.

[5]  David Botstein,et al.  Diversity, topographic differentiation, and positional memory in human fibroblasts , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  H. Willard,et al.  Cell cycle–dependent localization of macroH2A in chromatin of the inactive X chromosome , 2002, The Journal of cell biology.

[7]  S. Winokur,et al.  Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress , 2003, Neuromuscular Disorders.

[8]  G. V. Ommen,et al.  Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy , 2003, Nature Genetics.

[9]  Kevin M Flanigan,et al.  Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. , 2003, Human molecular genetics.

[10]  H. Willard,et al.  Chromatin of the Barr body: histone and non-histone proteins associated with or excluded from the inactive X chromosome. , 2003, Human molecular genetics.

[11]  M. Ehrlich,et al.  Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q. , 2003, Human molecular genetics.

[12]  N. Takagi,et al.  Regional and temporal changes in the pattern of X-chromosome replication during the early post-implantation development of the female mouse , 2004, Chromosoma.

[13]  U. Bengtsson,et al.  Localization of 4q35.2 to the nuclear periphery: is FSHD a nuclear envelope disease? , 2004, Human molecular genetics.

[14]  M. Ehrlich,et al.  Cytogenetic and immuno-FISH analysis of the 4q subtelomeric region, which is associated with facioscapulohumeral muscular dystrophy , 2004, Chromosoma.

[15]  J. Lawrence,et al.  The 4q subtelomere harboring the FSHD locus is specifically anchored with peripheral heterochromatin unlike most human telomeres , 2004, The Journal of cell biology.

[16]  G. Campbell,et al.  Comparison of vascular smooth muscle cells from adult human, monkey and rabbit in primary culture and in subculture , 1977, Cell and Tissue Research.

[17]  R. Frants,et al.  The D4Z4 repeat-mediated pathogenesis of facioscapulohumeral muscular dystrophy. , 2005, American journal of human genetics.

[18]  M. Lipinski,et al.  Chromatin loop domain organization within the 4q35 locus in facioscapulohumeral dystrophy patients versus normal human myoblasts. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Gilbert,et al.  Uncoupling global and fine-tuning replication timing determinants for mouse pericentric heterochromatin , 2006, The Journal of cell biology.

[20]  Stephen Dalton,et al.  Activin A Efficiently Specifies Definitive Endoderm from Human Embryonic Stem Cells Only When Phosphatidylinositol 3‐Kinase Signaling Is Suppressed , 2007, Stem cells.

[21]  A. Rosa,et al.  The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein , 2007, Neuromuscular Disorders.

[22]  S. Welle,et al.  Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy , 2007, Neurology.

[23]  H. Qian,et al.  DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1 , 2007, Proceedings of the National Academy of Sciences.

[24]  B. Chadwick,et al.  DXZ4 chromatin adopts an opposing conformation to that of the surrounding chromosome and acquires a novel inactive X-specific role involving CTCF and antisense transcripts. , 2008, Genome research.

[25]  Troy Stevens,et al.  Lung vascular cell heterogeneity: endothelium, smooth muscle, and fibroblasts. , 2008, Proceedings of the American Thoracic Society.

[26]  Dirk Schübeler,et al.  Global Reorganization of Replication Domains During Embryonic Stem Cell Differentiation , 2008, PLoS biology.

[27]  M. Kyba,et al.  An isogenetic myoblast expression screen identifies DUX4‐mediated FSHD‐associated molecular pathologies , 2008, The EMBO journal.

[28]  M. Lacey,et al.  Epigenetics of a tandem DNA repeat: chromatin DNaseI sensitivity and opposite methylation changes in cancers , 2008, Nucleic acids research.

[29]  Ichiro Hiratani,et al.  ReplicationDomain: a visualization tool and comparative database for genome-wide replication timing data , 2008, BMC Bioinformatics.

[30]  Rune R. Frants,et al.  Specific Loss of Histone H3 Lysine 9 Trimethylation and HP1γ/Cohesin Binding at D4Z4 Repeats Is Associated with Facioscapulohumeral Dystrophy (FSHD) , 2009, PLoS genetics.

[31]  M. Mora,et al.  Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation , 2009, BMC Biology.

[32]  I. Amit,et al.  Comprehensive mapping of long range interactions reveals folding principles of the human genome , 2011 .

[33]  Michael O Dorschner,et al.  Sequencing newly replicated DNA reveals widespread plasticity in human replication timing , 2009, Proceedings of the National Academy of Sciences.

[34]  Daniel G. Miller,et al.  RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy. , 2009, Human molecular genetics.

[35]  Jean Thierry-Mieg,et al.  Predictable dynamic program of timing of DNA replication in human cells. , 2009, Genome research.

[36]  T. Furey,et al.  DNaseI hypersensitivity at gene-poor, FSH dystrophy-linked 4q35.2 , 2009, Nucleic acids research.

[37]  R. Frants,et al.  Common epigenetic changes of D4Z4 in contraction‐dependent and contraction‐independent FSHD , 2009, Human mutation.

[38]  Edward J Oakeley,et al.  Chromatin state marks cell-type- and gender-specific replication of the Drosophila genome. , 2009, Genes & development.

[39]  B. Chadwick.  Macrosatellite epigenetics: the two faces of DXZ4 and D4Z4 , 2009, Chromosoma.

[40]  David M. Gilbert,et al.  Domain-wide regulation of DNA replication timing during mammalian development , 2009, Chromosome Research.

[41]  Daniel G. Miller,et al.  A Unifying Genetic Model for Facioscapulohumeral Muscular Dystrophy , 2010, Science.

[42]  S. Dalton,et al.  Evolutionarily conserved replication timing profiles predict long-range chromatin interactions and distinguish closely related cell types. , 2010, Genome research.

[43]  G. Carnac,et al.  Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects , 2008, Journal of cellular and molecular medicine.

[44]  Amos Tanay,et al.  Comparative Analysis of DNA Replication Timing Reveals Conserved Large-Scale Chromosomal Architecture , 2010, PLoS genetics.

[45]  Daniel G. Miller,et al.  Facioscapulohumeral Dystrophy: Incomplete Suppression of a Retrotransposed Gene , 2010, PLoS genetics.

[46]  Bernadett Papp,et al.  Genome-wide dynamics of replication timing revealed by in vitro models of mouse embryogenesis. , 2010, Genome research.

[47]  E. Gilson,et al.  Replication Timing of Human Telomeres Is Chromosome Arm–Specific, Influenced by Subtelomeric Structures and Connected to Nuclear Localization , 2010, PLoS genetics.

[48]  Ichiro Hiratani,et al.  Replication Timing: A Fingerprint for Cell Identity and Pluripotency , 2011, PLoS Comput. Biol..

[49]  M. Lacey,et al.  Gene expression during normal and FSHD myogenesis , 2011, BMC Medical Genomics.

[50]  Tyrone Ryba,et al.  Genome-scale analysis of replication timing: from bench to bioinformatics , 2011, Nature Protocols.

[51]  Mark Groudine,et al.  On emerging nuclear order , 2011, The Journal of cell biology.